The new era of data informatics tools can help providers and payers understand the tiers of risk that determine the economics of care delivery, which is crucial to value-based cancer treatment, according to Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology
The new era of data informatics tools can help providers and payers understand the tiers of risk that determine the economics of care delivery, which is crucial to value-based cancer treatment, according to Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology.
Transcript (slightly modified)
Patients with more advanced disease could result in higher costs and worse outcomes. Do risk-based payment models account for this?
So you’re kind of talking to an area that I find fascinating. In my current role at the City of Hope I work as the director of value-based analytics, and part of that is trying to figure out the global cost of care, but I think the other part of it, which I think is the key to mastering economic sustainability, particularly at academic cancer centers, is understanding how clinical risk translates into the cost of care delivery.
I think when we engage payers on these issues of value, if we look simply at a blanket diagnosis then we do a disservice both to the payer and to ourselves. Our value proposition is predicated upon really understanding the cost structure of delivering care, and understanding the, I would say, deep-seated connections between someone’s genomics, someone’s proteomics, the nature of their cancer, their comorbidities, so that we can talk more meaningfully about this patient and their projected cost of care.
So I think ultimately what we have to look toward is as we can leverage this enormously powerful era of data informatics to understand the tiers of risk within a particular diagnosis, I think you get both physicians and healthcare systems as well as payers into a different mindset of how best to model the economics of care delivery, and probably can serve as the basis for the creative development of new risk-based payment schemes.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen